Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 06:08 am Sale | 2022-12-31 | 13G | ToughBuilt Industries, Inc. TBLT | Mitchell P. Kopin | 4,716 1.200% | -1,919 (-28.92%) | Filing History |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | Performance Shipping Inc. PSHG | Mitchell P. Kopin | 266,666 6.200% | 266,666 (New Position) | Filing History |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX | Mitchell P. Kopin | 10,733 9.600% | 10,733 (New Position) | Filing History |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,686 7.600% | 6,686 (New Position) | Filing History |
| 2023-02-08 06:07 am Unchanged | 2022-12-31 | 13G | Globus Maritime Limited GLBS | Mitchell P. Kopin | 1,959,250 8.700% | 0 (Unchanged) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 90,204 5.600% | 82,687 (+1100.00%) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Histogen Inc. HSTO | Mitchell P. Kopin | 240,375 5.300% | 240,375 (New Position) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Mitchell P. Kopin | 19,197 9.000% | 19,197 (New Position) | Filing History |
| 2023-02-08 06:07 am Purchase | 2022-12-31 | 13G | Hoth Therapeutics, Inc. HOTH | Mitchell P. Kopin | 57,008 4.200% | 57,008 (New Position) | Filing History |
| 2023-02-08 06:06 am Sale | 2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 54,600 6.300% | -14,007 (-20.42%) | Filing History |
| 2023-02-08 06:06 am Sale | 2022-12-31 | 13G | Solana Company HSDT | Mitchell P. Kopin | 40 5.100% | -27 (-40.00%) | Filing History |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 76 9.400% | 76 (New Position) | Filing History |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ | Mitchell P. Kopin | 27,092 5.100% | 27,092 (New Position) | Filing History |
| 2023-02-08 06:06 am Unchanged | 2022-12-31 | 13G | Guardion Health Sciences, Inc. GHSI | Mitchell P. Kopin | 5,000,000 7.500% | 0 (Unchanged) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Synaptogenix, Inc. SNPX | Mitchell P. Kopin | 31,468 9.990% | 31,468 (New Position) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 1,918,959 9.990% | 687,477 (+55.83%) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL | Mitchell P. Kopin | 540 9.990% | 227 (+72.64%) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 8,739 5.700% | 8,739 (New Position) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Aditxt, Inc. ADTX | Mitchell P. Kopin | 0 5.800% | 0 (+1.38%) | Filing |
| 2022-12-09 08:20 am Purchase | 2022-11-30 | 13G | WiSA Technologies, Inc. WISA | Mitchell P. Kopin | 236 4.990% | 209 (+775.30%) | Filing History |